FDA Commissioner Scott Gottlieb, MD, issues statement regarding disclosure of retailer information; Agency then announces new ‘Draft Guidance’ that sets criteria for making previously-confidential information public for certain types of recalls.
On September 26, 2018, the Food and Drug Administration (FDA) issued a statement by Commissioner Scott Gottlieb, MD, about the FDA’s new policy to disclose retailer information for certain food recalls in an effort to improve consumer safety. Then, just one day later, the FDA published a notice announcing the creation of a new ‘Draft Guidance’ - the second in a series of policy steps the agency is taking as part of a broader plan to improve oversight of food safety and the recall process.
Here is a bit of background on FDA recall regulations:
“We recognize that an important part of the recall process is arming consumers with actionable information that they can use to avoid potentially contaminated food products,” says Dr. Gottlieb. “This is an area where we see more opportunity to improve the FDA’s role in protecting public health. To promote these goals, we’re advancing an important new policy.”
New Draft Guidance Makes More Info Available
The FDA’s practice has always been to assess each recall on a case-by-case basis to determine the kind of information that may be helpful to the public and consumers. However, according to the new Draft Guidance, there are specific circumstances when the FDA intends to make public the retail locations that may have sold or distributed a recalled human or animal food. Those criteria include:
“Americans depend on the U.S. Food and Drug Administration to help ensure that the foods they buy and consume are safe,” Dr. Gottlieb explains. “When we learn that potentially dangerous food products may be available in the U.S. marketplace, we must move quickly and efficiently to remove these food products from the market.”
Dr. Gottlieb admits that identifying retail locations that have sold a recalled product can be complex, since it can involve obtaining information from multiple stakeholders throughout the supply chain. He also states that the FDA may not be able to fully verify the accuracy or completeness of the information it receives from recalling companies or distributors, as that information may change over time.
Traceability - The Key to Recalls
The FDA’s move to implement new recall protocols is a clear indicator of the importance of traceability. It’s obvious that having company-wide visibility into your supply chain is an important part of your business success, but it is absolutely critical when your company is dealing with a recalled product. Time is of the essence, and having an accurate picture of that product’s journey can make the recall process easier, faster, and cheaper. But more than that, traceability is a crucial component in keeping the consumer safe.
FoodLogiQ’s Track + Trace food traceability software stitches together the critical tracking events of your products and ingredients at the batch-lot level to give you a real-time visualization of your supply chain. From grower to distribution center to the retailer or restaurant, you can get access to the data you need to take swift action when faced with a recall or outbreak. Our Investigations feature even helps you identify the root cause of the issue, enabling you to trace forward and launch a withdrawal of the affected product.
If you’re a part of the food supply chain, it’s not a matter of if your company will be affected by a recall; it’s simply a matter of when. To learn more about how FoodLogiQ can help you prepare, request a demo.